novartis.comvstakeda.com

Takeda edges out Novartis modestly on homepage messaging, 59 to 52. Here's where the gap comes from.

Novartis is clearer about what it does (33 vs 19 on clarity). Takeda is better at saying who it's for (ICP: 15 vs 0). Takeda's targeting is generic, while Novartis's is absent. Novartis has a much stronger pricing page (70 vs 0). Takeda doesn't have a detectable pricing page at all.

Both sites use the "Community / Movement" positioning archetype — they're competing on the same narrative, which means differentiation has to come from execution, not framing.